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Background: Endothelial dysfunction is characteristic of patients with essential hypertension but limited data are available on different aspects of 
endothelial function in patients with malignant phase hypertension (MHT).
Methods: We assessed flow mediated dilation (FMD) and response to glyceryltrinitrate (GTN) of brachial artery (ultrasound), laser Doppler 
with iontophoresis of acetylcholine (ACH) and sodium nitroprusside (SNP), pulse wave velocity (PWV), aortic augmentation index (AI), circulating 
endothelial cells (CEC) and endothelial progenitor cells (EPC) in 15 patients with MHT, 40 matched patients with ‘high risk’ hypertension (HHT), and 
40 healthy controls (HC). Myocardial contrast echocardiography (MCE) was also performed at rest and following dipyridamole challenge to calculate 
myocardial blood flow reserve (MBFR).
Results: Patients with MHT had impaired response to ACH, increased CECs, EPCs and PWV compared to HHT and HC (Table). Both hypertensive 
groups had impaired FMD compared to HC (p<0.05). MBFR was lower in MHT compared to HHT (1.62±0.38 vs 1.76±0.91; P=NS) and HC 
(1.62±0.38 vs 3.42±1.02; P<0.001) groups. No significant differences in AI, FMD, response to GTN and SNP were detected between patients with 
MHT and HHT.
Conclusions: Patients with MHT had significantly more pronounced abnormalities of endothelial macro- and micro-vascular function (including 
myocardial perfusion) compared to patients with HHT and HC, which may be associated with the aetiology of MHT.
Parameters of endothelial/vascular function in study groups
Malignant hypertension ‘High risk’ hypertension Healthy controls p
LD baseline, PU 0 .70 (0.6-0 .92)† 0.75 (0.60-0.83)‡ 0.51 (0.34-0.66) 0.001
Response in ACH (laser Doppler), % 21.8±10.2*† 97.3±57.6‡ 228±129 0.001
Response in SNP(laser Doppler), % 66.0±57.1† 103±41.1‡ 189±82.0 0.001
FMD, % 8.23±3.82† 7.02±4.33‡ 12.9±7.40 0.001
Response to GTN, % 12.2±4.39 11.4±5.76‡ 15.4±7.64 0.025
Pulse wave velocity, m/sec 7.23±2.30*† 6.03±1.35 5.64±0.91 0.003
EPC, ml 331 (149-447)*† 133 (62-190) 73 (36-212) 0.008
CEC, ml 313 (177-420)*† 85 (46-154) 79 (32-181) 0.001
*p<0.05 between MHT and both 
HHT and HC †p<0.05 between MHT and HC ‡p<0.05 between HHT and HC 79 (32-181) 0.001
